https://www.pharmaceutical-technology.com/data-insights/neratinib-puma-biotechnology-human-epidermal-growth-factor-receptor-2-negative-breast-cancer-her2-breast-cancer-likelihood-of-approval/
Neratinib is under clinical development by Puma Biotechnology and currently in Phase II for Human Epidermal Growth Factor Receptor 2 Negative Breast Cancer...
epidermal growth factorpuma biotechnologyneratinibhumanreceptor
https://pumabiotechnology.com/
Puma Biotechnology, Inc. is a biopharmaceutical company with a focus on the development and commercialization of innovative products to enhance cancer care....
puma biotechnologyinc
https://www.biospace.com/puma-biotechnology-presents-interim-results-from-the-biliary-tract-cancers-cohort-of-the-phase-ii-summit-basket-trial-of-neratinib-at-asco-gi
Puma Biotechnology, Inc. (NASDAQ: PBYI), a biopharmaceutical company, announced interim results from the biliary tract cancers cohort of the ongoing SUMMIT...
biliary tract cancerspuma biotechnologyinterim resultspresents
https://www.fool.com/investing/2022/11/21/why-puma-biotechnologys-shares-jumped-20-on-monday/
It may have benefited from positive news about another company's drug candidate.
puma biotechnologysharesjumpedmonday
https://www.barchart.com/stocks/quotes/PBYI/opinion
Trading Signals for Puma Biotechnology with Buy, Sell, Hold recommendations, technical analysis, and trading strategy.
puma biotechnologybarchartopinionstockcom